CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE
STERIMAX INC
Quick answers
Is there a shortage of CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE in Canada?
No. There is no current shortage of CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE 2MG reported to Health Canada. Stock can still vary from one pharmacy to another.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.
Low health risk
Possible match — not confirmed
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.
Low health risk
Possible match — not confirmed
DIN
02563266
Strength
2MG
Dosage Form
Solution
Route
Intravenous
Active Ingredient
CISATRACURIUM (CISATRACURIUM BESYLATE)
See all CISATRACURIUM (CISATRACURIUM BESYLATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from STERIMAX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02358328
200MG · DIN 02538431
50MG · DIN 02456524
20MG · DIN 00723754
1MG · DIN 02492768
500MG · DIN 02483890
50000UNIT · DIN 02245571
10MG · DIN 02413639
0.05MG · DIN 02413620
10MG · DIN 02413647
7.5MG · DIN 02460645
7.5MG · DIN 02504979